BACKGROUND: Practice variation in breast cancer surgery has raised concerns about the quality of treatment decisions. We sought to evaluate the quality of decisions about surgery for early-stage breast cancer by measuring patient knowledge, concordance between goals and treatments, and involvement in decisions. STUDY DESIGN: A mailed survey of stage I/II breast cancer survivors was conducted at 4 sites. The Decision Quality Instrument measured knowledge, goals, and involvement in decisions. A multivariable logistic regression model of treatment was developed. The model-predicted probability of mastectomy was compared with treatment received for each patient. Concordance was defined as having mastectomy and predicted probability Ͼ0.5 or partial mastectomy and predicted probability Ͻ0.5. Frequency of discussion about partial mastectomy was compared with discussion about mastectomy using chi-square tests.
Four hundred and forty patients participated (59% response rate). Mean overall knowledge was 52.7%; 45.9% knew that local recurrence risk is higher after breast conservation and 55.7% knew that survival is equivalent for the 2 options. Most participants (89.0%) had treatment concordant with their goals. Participants preferring mastectomy had lower concordance (80.5%) than those preferring partial mastectomy (92.6%; p ϭ 0.001). Participants reported more frequent discussion of partial mastectomy and its advantages than of mastectomy, and 48.6% reported being asked their preference. CONCLUSIONS: Breast cancer survivors had major knowledge deficits, and those preferring mastectomy were less likely to have treatment concordant with goals. Patients perceived that discussions focused on partial mastectomy, and many were not asked their preference. Improvements in the quality of decisions about breast cancer surgery are needed. (J Am Coll Surg 2012;214:1-11. © 2012 by the American College of Surgeons)
Geographic variation in rates of mastectomy and breastconserving surgery 1,2 has led to concerns about the quality of decisions about surgical treatment for early-stage breast cancer. 3 Even since the dissemination of recommendations in favor of breast-conservation therapy in the early 1990s, rates of mastectomy and partial mastectomy have varied by region, age, and race. [4] [5] [6] The decision about type of surgery for early-stage breast cancer is considered a "preferencesensitive decision" for patients who are clinically eligible for either option, because the best choice depends primarily on the patient's preferences. 7 For preference-sensitive decisions, an international consensus process has defined decision quality as the degree to which a decision is informed and concordant with patient preferences. 8, 9 The quality of decisions about surgical treatment for early-stage breast cancer in the United States is unclear. Breast cancer patients have reported unfulfilled information needs 10 and shown considerable deficits in knowledge about treatments. [11] [12] [13] Studies of patient knowledge have been limited by a lack of validated knowledge measures specific to the breast cancer surgery decision 12, 14 and a failure to consider specific treatment attributes besides recurrence and survival. 11, [15] [16] [17] [18] Validated and specific measures of preference concordance are also lacking. 19, 20 Although several studies have reported on which patient concerns affect decisions about surgery for breast cancer, [21] [22] [23] few have attempted to quantify the degree to which treatments reflect patient preferences. 24 The purpose of this study was to evaluate the quality of decisions about surgery for early-stage breast cancer. We specifically sought to measure patient knowledge about surgical options and to evaluate the degree to which treatments were concordant with patient preferences and goals. Secondary objectives were to identify factors associated with knowledge and to describe patient involvement in the decision-making process.
METHODS

Study design
We conducted a cross-sectional mailed survey of recent breast cancer survivors at 4 academic medical centers from October 2008 to February 2011. The institutional review board at each institution approved the study.
Patient population
Subjects included a sample of adult women with a history of early-stage invasive breast cancer (stages I, II) diagnosed 1 to 3 years before contact (2005 to 2010) and treated at 1 of 4 institutions (Dana-Farber Cancer Institute, Massachusetts General Hospital, University of California San Francisco, and University of North Carolina at Chapel Hill).
We excluded patients who had stage III or IV disease, ductal carcinoma in situ only, bilateral breast cancer, or neoadjuvant chemotherapy, and those who could not speak and read English.
Study design and procedures
Eligible patients were identified through each site's cancer registry. Permission to contact and confirmation of eligibility to participate were requested from each patient's provider. A modified Dillman survey method was followed. 25 Patients were mailed an introductory letter, survey instrument, consent forms, opt-out card, and packet of breast cancer awareness postage stamps (worth approximately $5). After 2 weeks, study staff members called patients who had not opted out to discuss the study, answer questions, and encourage survey completion. After another 2 weeks, a reminder packet was mailed to nonresponders. Participants received a thank you note with another packet of postage stamps. Each participant provided written informed consent.
Measures
The survey contained questions about demographics, clinical history, preferred treatment, perception of being informed, and the Decision Quality Instrument. Demographic, medical, and treatment data were obtained from the cancer registry. When a patient's report conflicted with the registry on a clinical issue (eg, stage), the medical record was examined.
Breast Cancer Surgery Decision Quality Instrument
The Breast Cancer Surgery Decision Quality Instrument contains items that cover 3 domains, ie, knowledge, goals and concerns, and involvement in decisions (see Appendix 1, online only). Domains were based on a consensus of clinicians, consumers, and medical decision-making experts, that defined decision quality as the degree to which the patient is informed, meaningfully involved in decision making, and receiving care that matches her goals. 8 The instrument has demonstrated feasibility of administration, acceptability to patients, discriminant validity, content validity (based on provider and patient reports), and strong retest reliability (intraclass correlation coefficient of 0.81) in this sample. 26 The instrument refers to partial mastectomy as lumpectomy to be more comprehensible to patients.
1. Knowledge. Twelve multiple-choice or fill-in-the-blank items about breast cancer and the local treatment options, including local recurrence, survival, and side effects. 2. Goals and concerns. Six items rated on a scale from 0 (not at all important) to 10 (extremely important). 3. Involvement. Seven multiple-choice items about the content of discussions with providers and how involved the patient was in decision making.
Preferred treatment
Single item: "Which option was your personal preference?" with responses "lumpectomy only," "lumpectomy with radiation," "mastectomy," or "I am not sure."
Treatment received
This was defined as the final treatment received, according to the cancer registry (and the chart, if the patient's report conflicted with the registry). In patients who had partial mastectomy followed by mastectomy, treatment received was defined as mastectomy.
Perception of being informed
Single item: "On a scale from 0 to 10, where 10 means extremely well-informed and 0 means not informed at all, how informed did you feel about surgical options for breast cancer?"
Statistical analysis Knowledge
The number of correct knowledge items was divided by the total number of knowledge items and multiplied by 100, resulting in a knowledge score from 0% to 100% for each patient. Quantitative, fill-in-the-blank items were considered correct if they fell within a range determined a priori by medical experts based on clinical evidence. An "I am not sure" response was considered incorrect, and missing responses were imputed with 1/k, where k was the number of possible responses. Knowledge scores were calculated for every respondent who completed at least 6 of 12 items. Chi-square tests were used to compare the percentage of partial mastectomy patients with correct answers to the percentage of mastectomy patients with correct answers, for each question. A 2-sample t-test was used to compare the mean knowledge scores between groups.
To identify characteristics associated with higher knowledge, univariate analysis with a 2-sample t-test or analysis of variance was performed. A multivariable linear regression model was created, including variables significant at the 0.05 level from univariate analysis. Association between perception of being informed and actual overall knowledge was summarized using Pearson's correlation coefficient.
Concordance score
To estimate the extent to which treatment received was associated with a patient's goals, we used the following approach, which has been described previously. 27 A multivariable logistic regression model of treatment (partial mastectomy vs mastectomy) was developed, including stage and the 6 goals and concerns as candidate predictors. Goals and concerns were included based on the premise that preference-sensitive decisions should incorporate the personal goals and concerns of the patient. Stage was included in the model to account for clinical appropriateness. Missing responses about goals were imputed from other available goal items. 28 The final concordance model included stage and those goals and concerns that were significant at the 0.05 level on multivariate analysis. The modelpredicted probability of mastectomy was then calculated for each patient based on the logistic regression model estimates. Patients with a predicted probability Ն0.5 who had mastectomy and those with a predicted probability Ͻ0.5 who had partial mastectomy were classified as having concordant care. The proportion of patients with concordant care was calculated for the sample. For these analyses, we excluded patients who had partial mastectomy followed by mastectomy.
Involvement
The frequency of discussion about partial mastectomy and its pros and cons was compared with the frequency of discussion about mastectomy and its pros and cons using chisquare tests.
RESULTS
Patient characteristics
We identified 769 potential participants, of whom providers excluded 23 (3.0%) as ineligible or unable to fully participate. Of the remaining 746 patients, 440 (59%) responded (Table 1) . Respondents were more likely to be white than nonresponders (85.2% vs 71.4%; p Ͻ 0.0001). Most respondents (n ϭ 272; 61.8%) had undergone partial mastectomy, 111 respondents (25.2%) had undergone initial mastectomy, and 57 respondents (13.0%) had undergone partial mastectomy followed by mastectomy (primarily to obtain negative margins). The 57 patients who had undergone partial mastectomy followed by mastectomy were classified as having undergone mastectomy.
Knowledge
Overall, participants' mean knowledge score was 52.7% (SD 21.8%) ( Table 2) . Fifty-eight percent of participants scored Ն50%.
Local recurrence
About half of participants (45.9%) knew that the risk of local recurrence is higher after partial mastectomy with radiation than after mastectomy. The remaining participants answered "there is no difference" (28.2%) or "I am not sure" (24.5%). Participants who had partial mastectomy were less likely to answer this question correctly (p Ͻ 0.0001).
A minority of participants could accurately estimate the 10-year risk of local recurrence after either surgical option. For the risk of local recurrence after partial mastectomy and radiation, 36.8% responded correctly (5% to 15% was considered correct). Incorrect responses were mostly overestimations (18.6%), and women who had partial mastectomy were more likely to answer correctly (p ϭ 0.016). For risk of local recurrence after mastectomy, 37.5% responded correctly (2% to 10% was considered correct). Incorrect responses were split between under (14.8%) and over (14.6%) estimations. Frequency of correct responses did not vary by treatment. For both questions, approximately one-third responded "I am not sure." Survival About half of participants (55.7%) knew that partial mastectomy with radiation and mastectomy resulted in equivalent survival, and 29.3% responded "I am not sure." Par-ticipants who had undergone partial mastectomy were more likely to answer this question correctly (p Ͻ 0.0001).
Specifics of breast-conservation therapy
Most (69.1%) knew that partial mastectomy was more likely to require reoperation for margins. A minority knew how many women who have partial mastectomy and radiation are very satisfied with appearance of the breast, with 28.4% correctly responding "most," 32.5% responding "some" or "a few," 5.0% responding "none," and 32.1% responding "I am not sure." Participants who had partial mastectomy were more likely to answer this question correctly. A minority knew the approximate prevalence of serious radiation side effects, with 26.8% correctly responding "fewer than 5%," 8.4% responding "5% to 10%," 4.3% responding "10% or higher," and 58.4% responding "I am not sure." Women who had partial mastectomy were more likely to answer this question correctly.
On multivariable analysis, younger age, white race, higher education, higher income, lower stage of disease, treatment with partial mastectomy, and more recent diagnosis were associated with higher knowledge (Table 3) . Overall, participants believed they were well-informed (mean 8.7 of 10, SD 1.7), but the perception of being informed did not correlate with their overall knowledge score (Pearson's coefficient 0.08; p ϭ 0.10). Knowledge scores did not vary significantly by site (Table 3) .
Concordance between goals and treatment Receipt of mastectomy was associated with 3 of the goals/ concerns on multivariable analysis (Table 4 ). The goals "remove your breast for peace of mind" and "avoid radiation" were positively associated with mastectomy, and the goal "keep your breast" was negatively associated with mastectomy. The overall concordance score, or percentage of patients who got the treatment predicted by the model, was 89.0%. Concordance was lower for mastectomy than for partial mastectomy. Specifically, women for whom the model predicted mastectomy received mastectomy 80.5% of the time, and women for whom the model predicted partial mastectomy received partial mastectomy 92.6% of the time (p ϭ 0.001). Treatment choice did not vary significantly by site (Table 3) . 
Involvement in decision making
Most participants (90.0%) reported that their providers discussed partial mastectomy as an option (Table 5) . Fewer (68.0%) reported a discussion of mastectomy as an option (p Ͻ 0.0001), and 58.6% reported a discussion of both options. More participants reported discussion about the reasons for partial mastectomy (75.5%) than discussion of the reasons for mastectomy (53.9%; p Ͻ 0.0001). Conversely, fewer participants reported discussion of the reasons against partial mastectomy (36.1%) than discussion of reasons against mastectomy (49.3%; p ϭ 0.0002). Most participants reported that the provider made a treatment recommendation (83.2%). Fewer than half (48.6%) reported that their provider asked their treatment preference.
DISCUSSION
For breast surgery, the quality of decisions can be judged by the extent to which patients are informed, involved in decision making, and undergoing treatments that reflect their goals. This study is the first to fully describe the quality of breast cancer surgery decisions along these 3 dimensions. In general, participants had substantial deficits in knowledge 1 to 3 years after diagnosis, including knowledge about local recurrence and survival. Their reports of discussions with providers suggested that patients were not always meaningfully involved in selecting treatments. Most participants had treatment that was concordant with their goals, but women who preferred mastectomy were less likely to have concordance than women who preferred partial mastectomy. Patients in this sample lacked knowledge about approximately half of the information that providers had identified as critical. Although we would expect patients to have forgotten some information since surgery (particularly the specific risk estimates), even the gist or summary information questions showed large knowledge gaps. For example, only half of the sampled patients knew that survival was the same for breast-conservation therapy and mastectomy. Women who had partial mastectomy were less knowledgeable about local recurrence than women who had mastectomy, despite being equally concerned about it. We found this somewhat concerning because patients who opt for partial mastectomy need to be aware of their slightly higher risk of local recurrence.
Our findings about knowledge concerning recurrence and survival are similar to other reports. In one populationbased study (limited to Detroit and Los Angeles), 26% of breast cancer survivors knew that local recurrence was higher after breast-conservation therapy, and 48% knew that survival was equivalent for breast-conservation therapy and mastectomy.
11 At 1 academic center, 45% of survivors knew that local recurrence was higher after breastconservation therapy, and 53% knew about the survival equivalence. 29 Our study confirms these findings, using a tested and validated knowledge measure.
Concordance between treatments and goals was relatively high, but a substantial minority of participants (18%) received treatment they did not prefer, and women who preferred mastectomy were more likely to receive discordant care. Some of this discordance might be related to providers' beliefs in the advantages of breast-conservation therapy. Patient reports on the interaction revealed that one-third of participants could not recall ever being presented with the option of mastectomy. About half of respondents reported that they were not asked for their treatment preference. In fact, they recalled providers making a recommendation twice as often as asking for patients' preferences. Some of the patients who had mastectomy might have had contraindications to breast conservation (eg, tumor size relative to breast size, earlier chest radiation). We attempted to minimize this possibility by having providers confirm eligibility, including stage in the treatment model, and excluding patients who had partial mastectomy followed by mastectomy from the concordance analysis. Women who prefer mastectomy might be lacking support from some providers and requiring greater effort to obtain the treatments they prefer. Breast surgeons tend to prefer breast-conservation therapy to mastectomy, 30 and they report frequent conflicts with patients who are eligible for breast conservation but want mastectomy. 31 A growing body of research is finding that some women who are highly informed and have no clinical contraindication to breast conservation still prefer mastectomy. 24, 32 In addition, greater involvement in the decision-making process has been associated with choice of mastectomy. 32, 33 The retrospective design of this study has important limitations. Participants might have forgotten information, so knowledge at the time of decisions might have been higher than what we measured. In addition, participants' reports of their goals and concerns might have been affected by recall bias, in which a person's experiences after an event influence her memories and perceptions of that event. For example, a patient who chose breast-conservation therapy and then experienced substantial anxiety with each surveillance mammogram might have been more likely to report a high level of concern about recurrence than she actually had at the time of decision making. A prospective study measuring decision quality closer to the time of decisions would shed light on the direction and magnitude of these potential biases.
Recall bias could also affect participants' report of their interaction with providers, with patients tending to have more memory of discussions about the treatments they received. Evaluating this would be possible through comparison of patient report with documentation in the medical record or to audiorecordings of the clinical encounter. Such approaches could provide insight into these processes in the future.
The study population had relatively high proportions of white, younger, educated, and higher-income patients. The sample came exclusively from academic medical centers and included English-speaking women only. We are uncertain how other populations would differ in terms of patient goals and treatments received. Because our population had relatively good access to health care, we hypothesize that other more vulnerable populations might have larger knowledge deficits and lower concordance. Some variation in patient knowledge and preferences by site might have existed, despite our attempts to achieve uniformity by using the same eligibility criteria, enrollment approaches, and data collection methods across sites. We did not find differences in knowledge or treatment by site, but the sample size was not large enough to detect small differences. Future studies should seek to replicate or disconfirm our findings in more diverse settings and with more diverse populations.
Making improvements in the quality of breast cancer surgical decisions will require interventions to enhance patient knowledge and promote incorporation of preferences into treatment decisions. Decision aids are tools designed to inform patients about key facts, help them clarify preferences, and prepare them for interaction with providers. They have proven effective at improving knowledge, reducing decisional conflict, and increasing participation in decisions. 34 Specific decision aids for breast cancer surgery have demonstrated improvements in knowledge about recurrence and survival. 12, 14 Communication aids, such as question lists and consultation audiorecordings, increase question-asking and information recall, respectively. 35, 36 Integration of decision and communication aids into the routine delivery of breast cancer care has been successful at some centers. 24, 37, 38 
CONCLUSIONS
Our study demonstrated that early-stage breast cancer survivors had deficits in breast cancer knowledge, and those who preferred mastectomy were less likely to receive treatment that was concordant with their preferences. Patients recalled the discussion of surgical options as tending to focus on breast-conservation therapy and its advantages, and many patients reported they were not asked for their treatment preference. Overall, improvements in the quality of decisions about surgery for early-stage breast cancer are needed.
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The majority of women presenting with early-stage breast cancer face a myriad of treatment options, including multiple types of primary surgical treatment. Within the past century, options have expanded from radical mastectomy as the sole standard treatment to new choices, including partial mastectomy, oncoplastic resection, total mastectomy with or without reconstruction, and contralateral breast procedures. The availability of these different yet equally effective surgical options, together with the many personal factors involved in the choice of breast cancer surgery, provides an ideal opportunity for patient education and shared decision-making. The study by Lee and colleagues adds to the body of literature exploring this interesting and important process, and indicates areas where improvement is needed. The authors describe the decisionmaking experience of woman undergoing breast cancer surgery. They report that a substantial number of these patients lacked a fundamental knowledge about recurrence and survival data related to the choices of breast cancer surgery. The authors also report varying levels of patient involvement in surgical decision-making, as well as disparities in the surgical treatment options made available to them. Because these data were obtained exclusively from a survey administered to patients 1 to 3 years after treatment was completed, it is uncertain whether these findings reflect a failure of surgeons to educate patients or a failure of patients to retain and recollect this information. Despite this limitation, the study uncovers potential gaps and deficiencies in the process of informing patients about their options for breast cancer surgery and actively engaging them in the decision process. These findings are similar to those from other studies and represent a somewhat disturbing phenomenon.
has been advocated widely as a hallmark of quality in health care. 5 The process goes beyond traditional informed consent and involves a system of patient education that often includes independent patient study, formally eliciting and integrating patients' treatment priorities and preferences, and then arriving at a mutually agreed upon course of treatment. Several patient education and decision-aid tools have been developed to facilitate this process and have been used successfully in practice. 6 The American College of Surgeons has also developed tools to aid patient education. 7 Admittedly, the process can be difficult to implement and time consuming, and adding to the challenge are findings that some patients desire less involvement in treatment decisions than others. 8 The authors also shed light on the possibility that surgeons are "selling" partial mastectomy to patients who would otherwise desire alternative surgical treatments for their breast cancer. This finding supports previous studies challenging the assumption that higher mastectomy rates are the result of surgeon bias and uninformed patients. [9] [10] [11] There are many reasons why a well-informed, educated, and involved patient might choose to undergo a mastectomy despite being a candidate for breast conservation, although it is important to ensure that misinformation is not one of them. However, once this has been assured, it is paramount that patients' preferences be fully respected and all options presented. Studies suggest that there is no uniform decision for breast cancer surgery that is associated with highest long-term patient satisfaction. Rather, it is achieving the desired level of involvement in the decision process that leads to patient satisfaction with their choice of surgery, the health care process, and the treatment team. 12, 13 Ironically, the pendulum might have swung to the point where efforts are needed to ensure that patients are being equally informed of their option for mastectomy.
The insights gleaned from this study and others like it enhance our understanding of what is actually occurring in our clinical encounters. This information can guide us in removing barriers to patient-centered care and help us to implement systems that empower patients and allow us to partner with them in their care decisions. These include systems that help patients understand competing risks and benefits of treatment options, enable them to clearly convey their treatment preferences and priorities, and determine their desired level of involvement in decisionmaking. This is our professional and ethical responsibility and a cornerstone of good patient care.
